Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
McKesson
Merck
Express Scripts
Moodys

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,683,051

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,683,051 protect, and when does it expire?

Patent 7,683,051 protects DUAVEE and is included in one NDA.

This patent has twenty-three patent family members in twenty-one countries.

Summary for Patent: 7,683,051
Title:Crystalline polymorph of bazedoxifene acetate
Abstract: The present invention is directed to a crystalline polymorph of bazedoxifene acetate, compositions containing the same, preparations thereof, and uses thereof.
Inventor(s): Demerson; Christopher (Kirkland, CA), Iera; Silvio (Montreal, CA), Ali; Kadum A. (Congers, NY)
Assignee: Wyeth (Madison, NJ)
Application Number:11/100,983
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Formulation;

Drugs Protected by US Patent 7,683,051

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Wyeth Pharms DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes   Start Trial   Start Trial Y Y PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS   Start Trial
Wyeth Pharms DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes   Start Trial   Start Trial Y Y TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,683,051

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 048527   Start Trial
Australia 2005233133   Start Trial
Brazil PI0509191   Start Trial
Canada 2561010   Start Trial
China 1938272   Start Trial
Costa Rica 8615   Start Trial
Ecuador SP066911   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Johnson and Johnson
McKinsey
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.